Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-05-21

FDA Approved: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — Original Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved Lupin Pharmaceuticals' original generic application for a fixed-dose combination tablet of losartan potassium and hydrochlorothiazide, expandin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Losartan potassium and hydrochlorothiazide (losartan potassium and hydrochlorothiazide)

Snippet

ORIG AP for LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE)